Borgeson Blake — SEC Form 4 filings
SEC reporting owner CIK 1856094. 39 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2024-01-11 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 35 legs across 33 filings — 1,334,923 shares, $6,990,506 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 220,000 shares @ $4.37 ($961,400) in RECURSION PHARMACEUTICALS, INC., filed 2025-12-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | Director | 39 | — | 35 legs · 1,334,923 sh · $6,990,506 | 8 |
Form 4 filings — Borgeson Blake
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 30,000 @ $3.34 | EDGAR |
| 2026-08-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 30,000 @ $3.25 | EDGAR |
| 2026-07-09 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 40,000 @ $3.96 | EDGAR |
| 2026-06-22 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 88,424 @ $0 | EDGAR |
| 2026-06-04 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 30,000 @ $3.68 | EDGAR |
| 2026-05-07 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 30,000 @ $3.52 | EDGAR |
| 2026-04-08 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 30,000 @ $3.10 | EDGAR |
| 2026-03-04 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 170,000 @ $3.46 | EDGAR |
| 2026-02-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 220,000 @ $4.20 | EDGAR |
| 2026-01-08 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 220,000 @ $4.36 | EDGAR |
| 2025-12-04 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 220,000 @ $4.37 | EDGAR |
| 2025-06-23 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 22,016 @ $0 · Grant/award (A): 44,031 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,734 @ $0 | EDGAR |
| 2024-11-14 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $7.64 | EDGAR |
| 2024-10-31 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $6.72 | EDGAR |
| 2024-10-17 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $6.67 | EDGAR |
| 2024-10-04 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 2,026 @ $0 | EDGAR |
| 2024-10-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $6.22 | EDGAR |
| 2024-09-19 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $6.84 | EDGAR |
| 2024-09-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $6.27 | EDGAR |
| 2024-08-22 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $7.12 | EDGAR |
| 2024-08-08 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $6.82 | EDGAR |
| 2024-07-25 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $8.48 | EDGAR |
| 2024-07-11 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $7.32 | EDGAR |
| 2024-07-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 1,441 @ $0 | EDGAR |
| 2024-06-27 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $9.51 | EDGAR |
| 2024-06-13 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $8.45 | EDGAR |
| 2024-06-05 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Grant/award (A): 13,097 @ $0 · Grant/award (A): 26,193 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $9.17 | EDGAR |
| 2024-05-16 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 20,054 @ $10.12 | EDGAR |
| 2024-05-02 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $7.95 | EDGAR |
| 2024-04-18 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $7.66 | EDGAR |
| 2024-04-03 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $8.82 | EDGAR |
| 2024-03-21 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 20,054 @ $10.79 | EDGAR |
| 2024-03-07 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 20,054 @ $12.06 | EDGAR |
| 2024-02-21 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 19,745 @ $12.31 · Sale (S): 309 @ $13.04 | EDGAR |
| 2024-02-08 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 11,447 @ $9.30 | EDGAR |
| 2024-01-25 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 20,054 @ $10.58 | EDGAR |
| 2024-01-11 | 4 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Sale (S): 6,303 @ $13.21 · Sale (S): 13,751 @ $13.81 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1856094 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →